| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,485 |
20,164 |
$872K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,544 |
12,797 |
$791K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,483 |
5,357 |
$291K |
| 99051 |
|
9,860 |
9,402 |
$177K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,884 |
7,578 |
$78K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,249 |
2,167 |
$60K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,516 |
2,165 |
$36K |
| 87276 |
|
1,952 |
1,870 |
$21K |
| 87275 |
|
1,952 |
1,869 |
$20K |
| 94060 |
|
552 |
506 |
$16K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
868 |
626 |
$12K |
| 83013 |
|
219 |
211 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
106 |
105 |
$9K |
| 81002 |
|
3,980 |
3,837 |
$9K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
145 |
143 |
$8K |
| 81025 |
|
1,071 |
1,044 |
$6K |
| 86580 |
|
651 |
620 |
$3K |
| 83014 |
|
206 |
198 |
$1K |
| 36416 |
|
394 |
381 |
$1K |
| 82962 |
|
478 |
458 |
$939.31 |
| 94664 |
|
135 |
132 |
$866.85 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
89 |
74 |
$374.50 |
| 36415 |
Collection of venous blood by venipuncture |
13 |
13 |
$24.75 |
| J7610 |
Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
17 |
12 |
$0.66 |